Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngine™, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science.
Future Fields is a proud business member of 1% for the Planet, a global organization that accelerates smart environmental giving. We are also a part of the United Nations Global Compact initiative, committing to aligning strategies and operations with universal principles on human rights, labor, environment and anti-corruption, and taking actions that advance societal goals.
Learn more about how we’re transforming science for the future at https://futurefields.io/.
Company Details
- Employees
- 43
- Address
- 11130 105 Ave Nw, Edmonton,alberta T5h 0l5,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- futurefields.io
- HQ
- Edmonton, Alberta
Future Fields Questions
Future Fields's website is futurefields.io
Future Fields's LinkedIn profile is https://ca.linkedin.com/company/future-fields
Future Fields has
43 employees.
View email and phone details for 43
employees at Future Fields.
Future Fields's industry is
Biotechnology Research
Future Fields's top competitors are
Nanostics Inc.,
Northern Rna Inc.,
Bioalberta,
Fluid Biomed Inc.,
Providence Therapeutics,
Entos Pharmaceuticals,
Pulsemedica,
Nimble Science,
Syantra Inc.,
Nanotess.
Future Fields's categories are Biotechnology Research
